MX2 and cancer: MX2 has not been reported as a prognostic marker for cancer therapy but is associated with promoting neutrophil migration.45,46 Here, we combined transcriptomic data, IHC staining results, and a deep-learning model to establish MTC prognostic indicators for LSCC with significant clinical guidance potential.